GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (SGX:T14) » Definitions » Cyclically Adjusted PB Ratio

Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Cyclically Adjusted PB Ratio : 5.10 (As of Jun. 05, 2024)


View and export this data going back to 1997. Start your Free Trial

What is Tianjin Pharmaceutical Da Ren Tang Group Cyclically Adjusted PB Ratio?

As of today (2024-06-05), Tianjin Pharmaceutical Da Ren Tang Group's current share price is $2.55. Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $0.50. Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted PB Ratio for today is 5.10.

The historical rank and industry rank for Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted PB Ratio or its related term are showing as below:

SGX:T14' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.55   Med: 4.92   Max: 11.35
Current: 5.04

During the past years, Tianjin Pharmaceutical Da Ren Tang Group's highest Cyclically Adjusted PB Ratio was 11.35. The lowest was 2.55. And the median was 4.92.

SGX:T14's Cyclically Adjusted PB Ratio is ranked worse than
83.15% of 730 companies
in the Drug Manufacturers industry
Industry Median: 1.885 vs SGX:T14: 5.04

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Tianjin Pharmaceutical Da Ren Tang Group's adjusted book value per share data for the three months ended in Mar. 2024 was $1.260. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.50 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Tianjin Pharmaceutical Da Ren Tang Group Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Pharmaceutical Da Ren Tang Group Cyclically Adjusted PB Ratio Chart

Tianjin Pharmaceutical Da Ren Tang Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.91 3.37 5.45 4.57 4.93

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.22 6.83 5.41 4.93 4.00

Competitive Comparison of Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted PB Ratio falls into.



Tianjin Pharmaceutical Da Ren Tang Group Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=2.55/0.5
=5.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Tianjin Pharmaceutical Da Ren Tang Group's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.26/115.2271*115.2271
=1.260

Current CPI (Mar. 2024) = 115.2271.

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.560 98.200 0.657
201409 0.584 98.900 0.680
201412 0.604 99.000 0.703
201503 0.627 99.900 0.723
201506 0.780 99.500 0.903
201509 0.774 100.500 0.887
201512 0.791 100.600 0.906
201603 0.806 102.200 0.909
201606 0.799 101.400 0.908
201609 0.808 102.400 0.909
201612 0.786 102.600 0.883
201703 0.807 103.200 0.901
201706 0.821 103.100 0.918
201709 0.867 104.100 0.960
201712 0.891 104.500 0.982
201803 0.954 105.300 1.044
201806 0.930 104.900 1.022
201809 0.893 106.600 0.965
201812 0.931 106.500 1.007
201903 0.993 107.700 1.062
201906 0.963 107.700 1.030
201909 0.951 109.800 0.998
201912 0.999 111.200 1.035
202003 1.024 112.300 1.051
202006 1.002 110.400 1.046
202009 1.070 111.700 1.104
202012 1.148 111.500 1.186
202103 1.196 112.662 1.223
202106 1.216 111.769 1.254
202109 1.249 112.215 1.283
202112 1.292 113.108 1.316
202203 1.338 114.335 1.348
202206 1.246 114.558 1.253
202209 1.235 115.339 1.234
202212 1.209 115.116 1.210
202303 1.301 115.116 1.302
202306 1.148 114.558 1.155
202309 1.151 115.339 1.150
202312 1.200 114.781 1.205
202403 1.260 115.227 1.260

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Tianjin Pharmaceutical Da Ren Tang Group  (SGX:T14) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Tianjin Pharmaceutical Da Ren Tang Group Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Business Description

Traded in Other Exchanges
Address
No. 17 Baidi Road, Zhong Xin Mansion, Nankai District, Tianjin, CHN, 300193
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.

Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Headlines

No Headlines